Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Stock-Based Compensation
$45.80M
TTM · Period ending: · USD
BIO Stock-Based Compensation
Latest reported$45.80Mperiod ending
Latest reported$45.80Mperiod ending
BIO TTM Stock-Based Comp ($0.00 → $45.80M)
TTM stock-based compensation
High-resolution chart · PNG
BIO stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 45,800,000 | |
| 30,500,000 | |
| 30,800,000 | |
| 31,300,000 | |
| 32,000,000 | |
| 62,300,000 | |
| 62,300,000 | |
| 62,100,000 | |
| 62,400,000 | |
| 60,000,000 | |
| 61,300,000 | |
| 63,200,000 | |
| 63,000,000 | |
| 64,000,000 | |
| 60,900,000 | |
| 57,800,000 | |
| 55,200,000 | |
| 53,000,000 | |
| 51,200,000 | |
| 48,500,000 | |
| 46,200,000 | |
| 43,600,000 | |
| 41,600,000 | |
| 39,500,000 | |
| 37,800,000 | |
| 36,800,000 | |
| 35,600,000 | |
| 34,000,000 | |
| 32,000,000 | |
| 30,400,000 | |
| 27,800,000 | |
| 25,986,000 | |
| 24,886,000 | |
| 23,886,000 | |
| 23,386,000 | |
| 21,982,000 | |
| 20,893,000 | |
| 20,455,000 | |
| 19,700,000 | |
| 19,009,000 | |
| 18,102,000 | |
| 17,574,000 | |
| 17,000,000 | |
| 16,495,000 | |
| 15,823,000 | |
| 15,270,000 | |
| 14,900,000 | |
| 14,520,000 | |
| 14,301,000 | |
| 13,919,000 | |
| 13,700,000 | |
| 13,846,000 | |
| 13,655,000 | |
| 13,546,000 | |
| 13,200,000 | |
| 12,132,000 | |
| 11,722,000 | |
| 11,053,000 | |
| 10,700,000 | |
| 10,659,000 | |
| 10,680,000 | |
| 10,697,000 | |
| 10,200,000 | |
| 7,357,000 | |
| 7,377,000 | |
| 6,909,000 | |
| 6,670,000 | |
| 6,670,000 | |
| 6,274,000 | |
| 5,737,000 | |
| 5,276,000 | |
| 5,276,000 | |
| 3,119,000 | |
| 1,586,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |